Status:

RECRUITING

Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions

Lead Sponsor:

Northwest Women's and Children's Hospital, Xi'an, Shaanxi

Conditions:

Infertility

Eligibility:

FEMALE

20-40 years

Phase:

NA

Brief Summary

This study aims to evaluate the efficacy of atosiban in patients with previous pregnancy failure and abnormal uterine contractions during the peri-embryo transfer period in assisted reproductive techn...

Eligibility Criteria

Inclusion

  • Participants/eligibility criteria
  • Infertile women who fulfill all of the following inclusion criteria, based on the results and findings of the Atosiban 1 study are eligible for participation:
  • Scheduled for single blastocyst-stage embryo transfer, either in a fresh or frozen transfer cycle;
  • Have a history of one or more episodes of implantation failures in previous embryo transfer cycles;
  • Age between 20 and 40 years (inclusive);
  • Exhibit abnormal uterine peristalsis on transvaginal ultrasound performed on the morning of the scheduled blastocyst transfer, defined as either: high-frequency peristalsis (\>4 contractions per minute), or a negative wave pattern (fundus-to-cervix direction) at any frequency.
  • Each woman could only participate in one transfer cycle.
  • Exclusion criteria
  • Immunologic or endocrine disorders including thyroid dysfunction, antiphospholipid syndrome, hyperprolactinemia and other severe systematic diseases (e.g., hypertension, diabetes, etc.)
  • Uterine malformations (e.g., intrauterine adhesions; unicornuate, bicornuate or septate uterus);
  • Untreated hydrosalpinx or endometrial polyp;
  • Cycles that included in-vitro maturation or oocyte donation;
  • Prior participation in Atosiban 1 study;
  • Current participation in any other clinical trial;
  • Inability to provide informed consent to the study.

Exclusion

    Key Trial Info

    Start Date :

    December 6 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2027

    Estimated Enrollment :

    792 Patients enrolled

    Trial Details

    Trial ID

    NCT07185230

    Start Date

    December 6 2025

    End Date

    September 30 2027

    Last Update

    December 9 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Center for Reproductive Medicine, Northwest Women's and Children's Hospital

    Xi'an, Shaanxi, China, 710003